Literature DB >> 11570816

VE-cadherin-derived cell-penetrating peptide, pVEC, with carrier functions.

A Elmquist1, M Lindgren, T Bartfai.   

Abstract

Cell-penetrating peptides, CPPs, have been shown to translocate into living cells by a receptor-independent mechanism and to carry macromolecules over the plasma membrane. This article reports studies of the internalization of pVEC, an 18-amino acid-long peptide derived from the murine sequence of the cell adhesion molecule vascular endothelial cadherin, amino acids 615-632. Fluorophore-labeled pVEC entered four different cell lines tested: human aortic endothelial cells, brain capillary endothelial cells, Bowes melanoma cells, and murine brain endothelial cells. In order to evaluate the translocation efficiency of pVEC, we performed a side-by-side comparison with penetratin, a well-characterized CPP. The cellular uptake of pVEC was highest for murine brain endothelial cells. All cell lines tested contained equal or slightly higher concentrations of pVEC than penetratin. pVEC mainly accumulated in nuclear structures but was also found throughout the cells. Furthermore, pVEC functioned as a transporter of both a hexameric peptide nucleic acid molecule of 1.7 kDa and a 67-kDa protein, streptavidin-FITC, and cellular uptake of fluorophore-labeled pVEC took place at 4 degrees C, suggesting a nonendocytotic mechanism of translocation. In conclusion, our results indicate that pVEC is efficiently and rapidly taken up into cells and functions as a potent carrier peptide. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11570816     DOI: 10.1006/excr.2001.5316

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  57 in total

1.  Gene delivery mediated by recombinant silk proteins containing cationic and cell binding motifs.

Authors:  Keiji Numata; Juliana Hamasaki; Balajikarthick Subramanian; David L Kaplan
Journal:  J Control Release       Date:  2010-05-10       Impact factor: 9.776

2.  Passage of cell-penetrating peptides across a human epithelial cell layer in vitro.

Authors:  Maria E Lindgren; Mattias M Hällbrink; Anna M Elmquist; Ulo Langel
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

3.  Metabolic cleavage of cell-penetrating peptides in contact with epithelial models: human calcitonin (hCT)-derived peptides, Tat(47-57) and penetratin(43-58).

Authors:  Rachel Tréhin; Hanne M Nielsen; Heinz-Georg Jahnke; Ulrike Krauss; Annette G Beck-Sickinger; Hans P Merkle
Journal:  Biochem J       Date:  2004-09-15       Impact factor: 3.857

Review 4.  Silk-based delivery systems of bioactive molecules.

Authors:  Keiji Numata; David L Kaplan
Journal:  Adv Drug Deliv Rev       Date:  2010-03-16       Impact factor: 15.470

Review 5.  Applying horizontal gene transfer phenomena to enhance non-viral gene therapy.

Authors:  Jacob J Elmer; Matthew D Christensen; Kaushal Rege
Journal:  J Control Release       Date:  2013-08-30       Impact factor: 9.776

Review 6.  Internalization of cationic peptides: the road less (or more?) traveled.

Authors:  S M Fuchs; R T Raines
Journal:  Cell Mol Life Sci       Date:  2006-08       Impact factor: 9.261

7.  Translocation of cell-penetrating peptides and delivery of their cargoes in triticale microspores.

Authors:  Archana Chugh; Eric Amundsen; François Eudes
Journal:  Plant Cell Rep       Date:  2009-03-15       Impact factor: 4.570

8.  Modulation of intercellular junctions by cyclic-ADT peptides as a method to reversibly increase blood-brain barrier permeability.

Authors:  Marlyn D Laksitorini; Paul K Kiptoo; Ngoc H On; James A Thliveris; Donald W Miller; Teruna J Siahaan
Journal:  J Pharm Sci       Date:  2015-01-12       Impact factor: 3.534

9.  Metabolic cleavage and translocation efficiency of selected cell penetrating peptides: a comparative study with epithelial cell cultures.

Authors:  Christina Foerg; Kathrin M Weller; Helene Rechsteiner; Hanne M Nielsen; Jimena Fernández-Carneado; René Brunisholz; Ernest Giralt; Hans P Merkle
Journal:  AAPS J       Date:  2008-06-28       Impact factor: 4.009

10.  Cell-penetrating peptide TP10 shows broad-spectrum activity against both Plasmodium falciparum and Trypanosoma brucei brucei.

Authors:  Romanico B G Arrighi; Charles Ebikeme; Yang Jiang; Lisa Ranford-Cartwright; Michael P Barrett; Ulo Langel; Ingrid Faye
Journal:  Antimicrob Agents Chemother       Date:  2008-06-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.